Malaga Cove Capital’s Pfizer PFE Stock Holding History

Malaga Cove Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,581	Closed	-$54K	–	150
2017 Q3	$54K	Buy	+1,581	New	+$50.8K	0.03%	141
2016 Q3	–	Sell	-18,548	Closed	-$522K	–	115
2016 Q2	$522K	Hold	18,548	–	–	0.43%	65
2016 Q1	$522K	Sell	18,548 -47	-0.3%	-$1.34K	0.43%	65
2015 Q4	$572K	Buy	+18,595	New	+$585K	0.41%	69

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Malaga Cove Capital's PFE Position: Q4 2017 in Review

Malaga Cove Capital sold out of Pfizer (PFE) in Q4 2017, closing a stake of 1,581 shares — an estimated $54K sold.

Malaga Cove Capital first reported a position in PFE in Q4 2015 and held it in 4 quarters. The position peaked at $572K in Q4 2015. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

Malaga Cove Capital reported no remaining Pfizer position as of Q4 2017 after selling out during the quarter.
Malaga Cove Capital sold 1,581 Pfizer shares in Q4 2017, an estimated $54K.
Malaga Cove Capital first reported a position in Pfizer in Q4 2015 and held it in 4 quarters.
Malaga Cove Capital's Pfizer position peaked at $572K in Q4 2015.
2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Malaga Cove Capital's 13F filing for Q4 2017, filed 31 Jan 2018.